FILE:CVS/CVS-8K-20020731094907.txt.gz
EVENTS:	
TEXT:
ITEM: 
- -------------------------------------------------------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 31, 2002 CVS CORPORATION (Exact Name of Registrant as Specified in its Charter) ---------------------- Delaware 001-01011 050494040 -------- --------- --------- (State or other jurisdiction of (Commission (IRS Employer incorporation or organization) File Number) Identification No.) One CVS Drive Woonsocket, Rhode Island 02895 ------------------------ ----- (Address of principal executive offices) (Zip Code) (401) 765-1500 -------------- (Registrant's telephone number, including area code) NOT APPLICABLE -------------- (Former name or former address, if changed since last report) - --------------------------------------------------------------------------------
Item 9. Regulation FD Disclosure On a regularly scheduled quarterly earnings call held on July 31, 2002, CVS Corporation announced that its Chief Executive Officer and Chief Financial Officer both intend to certify the company's periodic reports on a timely basis in accordance with the recently issued administrative order of the Securities Exchange Commission requiring the filing of sworn statements pursuant to Section 21(a)(1) of the Securities and Exchange Act of 1934.
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CVS CORPORATION By: /s/ David B. Rickard ------------------------------------------ David B. Rickard Executive Vice President, Chief Financial Officer and Chief Administrative Officer Dated: July 31, 2002


